Arantza Fariña Sarasqueta

The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients

Arantza Fariña Sarasqueta, Gesina van Lijnschoten, Elna Moerland et al. · Annals of Oncology · 2010 · 265 citations · Full text

Medicine, Molecular Genetics, Oncology +14

Impact of resection margin status on recurrence and survival in pancreatic cancer surgery

Willemieke S. Tummers, Jesse V. Groen, Babs G. Sibinga Mulder et al. · British journal of surgery · 2019 · 226 citations · Full text

Medicine, Oncology, Surgery +17

Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study

Leonora S. F. Boogerd, Charlotte E.S. Hoogstins, Dennis P. Schaap et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 197 citations · Full text

Medicine, Oncology, Surgery +17

A 40-Marker Panel for High Dimensional Characterization of Cancer Immune Microenvironments by Imaging Mass Cytometry

Marieke E. Ijsselsteijn, Ruud van der Breggen, Arantza Fariña Sarasqueta et al. · Frontiers in Immunology · 2019 · 163 citations · Full text

Medicine, Oncology, Pathology +16

Image-Guided Surgery in Patients with Pancreatic Cancer: First Results of a Clinical Trial Using SGM-101, a Novel Carcinoembryonic Antigen-Targeting, Near-Infrared Fluorescent Agent

Charlotte E.S. Hoogstins, Leonora S. F. Boogerd, Babs G. Sibinga Mulder et al. · Annals of Surgical Oncology · 2018 · 153 citations · Full text

Medicine, Oncology, Radiology +17